RT Journal
A1 Grady D
T1 Conservative use of prescription drugs: Comment on “communicating uncertainties about prescription drugs to the public”
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2011
FD September 12
VO 171
IS 16
SP 1470
OP 1470
DO 10.1001/archinternmed.2011.370
UL http://dx.doi.org/10.1001/archinternmed.2011.370
AB 
And unfortunately, after being informed that new drugs (which don't have a track record of safety) may be more dangerous than older drugs, and that drugs shown to improve surrogate outcomes may not actually prevent disease, a large proportion of persons still chose new drugs—and those without evidence of clinical benefit. Perhaps selecting the most clinically effective and safe drug should be the responsibility of properly trained clinicians.